Skip to content
healthcare.dev

Asclera

NDC 67850-141, POLIDOCANOL, injection, solution, from Methapharm, Inc.

Product NDC
67850-141
Status
Listed
Labeler
Methapharm, Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021201
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67850-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLIDOCANOL.01 g/mL

Pharmacologic classes

Sclerosing Activity [MoA]; Sclerosing Agent [EPC]; Vascular Sclerosing Activity [PE]

Package NDCNDC-11Package
67850-141-05678500141052 mL in 1 AMPULE (67850-141-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bb1f342b-5352-4059-a0b2-e60fd652fd28

Use it

Look up 67850-141 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67850-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67850-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.